FDA 483 - Southern Blood Services Inc - November 15, 2019

An FDA inspection of Southern Blood Services Inc, a plasma center in Nashville, TN, revealed significant issues with donor eligibility screening and equipment maintenance. The firm failed to defer ineligible donors based on hematocrit and pulse rate criteria, and also lacked proper procedures for the calibration and preventative maintenance of critical donor screening equipment.